New York CEO Conference
Date: Location: Cost:
Nov 12 - 13, 2013 Apella
450 East 29th Street,
New York, NY 10016
(212) 706.4100
Location >

Starting at $1975

 

Dress Code:
Business Attire

Register

November 12, 2013

Time Agenda
7:45-8:45 am

Registration & Networking Breakfast

8:45-9:30 am

Welcoming RemarksGeorge Yancopoulos, Regeneron; Sam Waksal, Kadmon; John Maraganore, Alnylam; Pablo Legorreta, Royalty Pharma; Ron Cohen, Acorda
Alexandria Ventures Healthcare OutlookAmanda Cashin, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

Co-hosts: Safi Bahcall, Ron Cohen, Michelle Dipp, Robert Forrester, Carl Gordon, Maxine Gowen, Yvonne Greenstreet, Arthur Hiller, Pablo Legorreta, John Maraganore, Joel Marcus, Sharon Mates, Kenneth Moch, Flemming Ornskov, Mark Pruzanski, Dennis Purcell, Rory Riggs, Marc Tessier-Lavigne, Sam Waksal, Christoph Westphal, George Yancopoulos

9:30-10:00 am

Healthcare Market Outlook: Will a Great 2013 Be Followed by an Even Better 2014?
Carl Gordon
, OrbiMed; Pablo Legorreta, Royalty Pharma; Nick Leschly, bluebird bio; Dennis Purcell, Aisling Capital
Moderator: Matthew Roden, UBS

10:00-10:20 am

Moderated Keynote: The Complimentary Relationship Between Pharmaceutical Companies and Patient Advocacy Organizations
John Maraganore, CEO, Alnylam
Moderator: Kenneth Moch, Chimerix

10:20-10:40 am

Moderated Keynote: Managing Transitions - From Platform to Portfolio to Product – An Inside Look at Human Genome Sciences, Inc.
Tom Watkins
, former CEO, Human Genome Sciences
Moderators: Maxine Gowen, Trevena and Marc Gerber, Skadden

10:40-11:10 am

Networking Break

11:10-11:40 am

The Hot IPO Window: Impact on Private Financing Deals
Bob Gallotto, Allena; Lissa Goldenstein, Auxogyn; Lisa McKerracher, BioAxone BioSciences; Malcolm Weir, Heptares Therapeutics; Mark Wiggins, Elcelyx Therapeutics
Moderator: Joseph Yanchik, Aileron Therapeutics

11:40-12:00 pm

Moderated Keynote: The Next/Best Ten Years in Biotech
RJ Kirk
, CEO, Intrexon Corporation
Moderator: Christoph Westphal, Verastem

12:00-1:00 pm

Networking Lunch – Tables hosted by co-hosts

Co-hosts: Safi Bahcall, Ron Cohen, Michelle Dipp, Robert Forrester, Carl Gordon, Maxine Gowen, Yvonne Greenstreet, Arthur Hiller, Pablo Legorreta, John Maraganore, Joel Marcus, Sharon Mates, Kenneth Moch, Flemming Ornskov, Mark Pruzanski, Dennis Purcell, Rory Riggs, Sam Waksal, Christoph Westphal, George Yancopoulos

1:00-1:30 pm

Non-Dilutive Financing: Where is the Cash Coming From and Will It Keep Flowing?
Robert Crane
, GI Dynamics; Jan-Anders Karlsson, Verona Pharma; Pieter Muntendam, scPharmaceuticals; Hans Schikan, Prosensa
Moderator: Peter Handrinos, Latham & Watkins

1:30-2:00 pm

Drug Discovery: Has PDUFA V Made a Difference?
JC Gutierrez-Ramos, Pfizer; John Maraganore, Alnylam; Sam Waksal, Kadmon; Doug Williams, Biogen Idec
Moderator: Michael Luther, AMRI

2:00-2:20 pm

Moderated Keynote: One Company's Transformation - Reflections and Insights
Elliott Sigal
, former President, Bristol-Myers Squibb
Moderator: Ron Cohen, Acorda

2:20-2:50 pm

Networking Break

2:50-3:20 pm

Reimbursement: Who's Going to Pay for Your Great New Drug?
Francois Nader, NPS Pharmaceuticals; Everett Neville, Express Scripts; Sam Rasty, Shire; Laurel Todd, BIO
Moderator: Ron Cohen, Acorda

3:20-3:40 pm

Moderated Keynote: Capital Attraction to Today's Biotechs
Bob Greifeld
, CEO, Nasdaq
Moderator: Matthew Rossiter, Fenwick & West

3:40-4:10 pm

IPOs, PIPES, Form 10s and Secondaries: Elements of Success
Marina Bozilenko
, William Blair; Dan Dubin, Leerink Swann; Mark Epstein, MTS Health Partners; Genghis Lloyd-Harris, Abingworth; Phil Ross, JPMorgan
Moderator: Bill Hicks, Mintz Levin

4:10-4:30 pm

Moderated Keynote: Building a World-Class Biotech Company from the Ground Up - The Story of Regeneron
George Yancopoulos, President, Regeneron
Moderator: Robert Forrester, Verastem

4:30-5:00 pm

Home Grown or Outsourced: How Do You Fill Your Pipeline?
Yvonne Greenstreet
, former Pfizer; Elliott Sigal, former Bristol-Myers Squibb; Willem van Weperen, to-BBB Technologies; Sam Waksal, Kadmon;
George Yancopoulos, Regeneron
Moderator: Pierre Jacquet, L.E.K. Consulting

5:00-5:20 pm

Fireside Chat
Adam Schechter, President, Merck; Brent Saunders, CEO, Forest
Moderator: Christoph Westphal, Verastem

5:20-6:20 pm

Cocktails and Hors d’oeuvres

Co-hosted by: Safi Bahcall, Ron Cohen, Michelle Dipp, Robert Forrester, Carl Gordon, Maxine Gowen, Yvonne Greenstreet, Arthur Hiller, Pablo Legorreta, John Maraganore, Joel Marcus, Sharon Mates, Kenneth Moch, Flemming Ornskov, Mark Pruzanski, Dennis Purcell, Rory Riggs, Marc Tessier-Lavigne, Sam Waksal, Christoph Westphal, George Yancopoulos

November 13, 2013

Time Agenda
7:30-8:30 am

Registration & Networking Breakfast

8:30-8:45 am

Welcoming RemarksSam Waksal, Kadmon; Mark Pruzanski, Intercept Pharma; Kenneth Moch, Chimerix; Pablo Legorreta, Royalty Pharma; Carl Gordon, OrbiMed
Alexandria Ventures Healthcare OutlookAmanda Cashin, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

Co-hosts: Safi Bahcall, Ron Cohen, Michelle Dipp, Robert Forrester, Carl Gordon, Maxine Gowen, Yvonne Greenstreet, Arthur Hiller, Pablo Legorreta, John Maraganore, Joel Marcus, Sharon Mates, Kenneth Moch, Flemming Ornskov, Mark Pruzanski, Dennis Purcell, Rory Riggs, Marc Tessier-Lavigne, Sam Waksal, Christoph Westphal, George Yancopoulos

8:45-9:15 am

How is Personalized Medicine Guiding Drug Development in 2013?
Tim Harris, Biogen Idec; Jeff Hatfield, Vitae Pharmaceuticals; David Meek, Endocyte; Chad Robins, Adaptive Biotechnologies; Neil Warma, Opexa Therapeutics
Moderator: Dan Grau, Heptares Therapeutics

9:15-9:45 am

Healthcare Private Equity: Predictions for 2014
Rich Aldrich
, Longwood Fund; Martin Friedman, Pharmakon Advisors; Jonathan Montagu, Nimbus Discovery; Michael Weinmann, Capital Royalty
Moderator: Mike Hanewich, Silicon Valley Bank

9:45-10:15 am

Pharma-Biotech Collaborations: Keys to Success
Maarten de Jong
, Barclays; George Golumbeski, Celgene; Arthur Hiller; Tony Rosenberg, Novartis; Hamza Suria, Anaptys
Moderator: John DeYoung, Pfizer

10:15-10:45 am

Challenges to the VC Investment Model
Brian Atwood
, Versant Ventures; Bernard Davitian, Sanofi; Jonathan Leff, Deerfield Partners; Deepa Pakianathan, Delphi Ventures; Peter Thompson, OrbiMed
Moderator: Stephen Bunting, Abingworth

10:45-11:05 am

Moderated Keynote: Building Biotech - A View from Academia and NYC
Marc Tessier-Lavigne
, President, Rockefeller University
Moderator: Christoph Westphal, Verastem

11:05-11:35 am

The Cost of Developing a Drug: Where Are We Now and How Can We Creatively Finance?
Iain Dukes, Merck; Steve Krognes, Genentech; Ron Squarer, Array BioPharma; Arthur Tzianabos, OvaScience
Moderator: Harald Stock, former Grunenthal

11:35-12:05 pm

Launching Drugs Successfully: Company Perspectives
Marc Beer
, Aegerion; Ron Cohen, Acorda; Claudia Hirawat, PTC Therapeutics
Moderator: Effie Toshav, Fenwick & West

12:05-12:50 pm

Networking Lunch – Tables hosted by co-hosts

Co-hosts: Safi Bahcall, Ron Cohen, Michelle Dipp, Robert Forrester, Carl Gordon, Maxine Gowen, Yvonne Greenstreet, Arthur Hiller, Pablo Legorreta, John Maraganore, Joel Marcus, Sharon Mates, Kenneth Moch, Flemming Ornskov, Mark Pruzanski, Dennis Purcell, Rory Riggs, Marc Tessier-Lavigne, Sam Waksal, Christoph Westphal, George Yancopoulos

12:50-1:20 pm

Moderated Keynote: FDA in a Changing World - Challenges and Opportunities for Advancing Biomedical Product Innovation
Peggy Hamburg
, Commissioner, Food & Drug Administration
Moderator: Michelle Dipp, OvaScience

1:20-1:50 pm

Innovative Deal Structures
Tony Gibney, Leerink Swann; Sean McCarthy, CytomX Therapeutics; Jason Rhodes, Epizyme; Bob Silverman, Hoffman-La Roche; Richard Soll, WuXi Apptec
Moderator: Barbara Yanni, Merck

1:50-2:20 pm

Oncology as the New Rare Disease: Trends to Watch for the Rest of the Industry
Safi Bahcall
, Synta Pharma; Ivan Bergstein, Stemline Therapeutics; Steve Bloom, Ziopharm Oncology;
 Dale Ludwig, ImClone; Steve Sherwin, Verastem
Moderator: Markus Warmuth, H3 Biomedicine

2:20-2:50 pm

Networking Break

2:50-3:10 pm

Moderated Keynote: Cystic Fibrosis as a New Paradigm of Precision Medicine
Jeff Leiden
, CEO, Vertex
Moderator: John Westwood, L.E.K. Consulting

3:10-3:40 pm

Biotech Valuations in 2013
Chris Collins
, Citi Healthcare; Robert Forrester, Verastem; Leland Gershell, TONIX Pharmaceuticals; Mathai Mammen, Theravance
Moderator: Mike King, JMP Securities

3:40-4:10 pm

Great Companies: Amazing Science or Killer Teams?
Jeremy Goldberg, Torreya Partners; Jill Milne, Catabasis; Carol Nacy, Sequella; Brian Pereira, Visterra; Rory Riggs, Balfour Capital
Moderator: Kenneth Moch, Chimerix

4:10-4:40 pm

Buyside Perspectives
Carl Gordon, OrbiMed; Noushin Irani, Deutsche Asset & Wealth Management; Oleg Nodelman, EcoR1 Capital; Joe Sum, First Manhattan
Moderator: David Sable, Special Situations Life Sciences Fund

4:40-5:00 pm

Moderated Keynote: NYC's Success in Diversification
Robert Steel
, Deputy Mayor for Economic Development
Moderator: John Cunningham, Alexandria Real Estate Equities, Inc.

5:00-6:00 pm

Presentation of NY CEO Lifetime Achievement Award and Cocktails
Presented by: George Yancopoulos, Regeneron

Co-hosted by: Safi Bahcall, Ron Cohen, Michelle Dipp, Robert Forrester, Carl Gordon, Maxine Gowen, Yvonne Greenstreet, Arthur Hiller, Pablo Legorreta, John Maraganore, Joel Marcus, Sharon Mates, Kenneth Moch, Flemming Ornskov, Mark Pruzanski, Dennis Purcell, Rory Riggs, Marc Tessier-Lavigne, Sam Waksal, Christoph Westphal, George Yancopoulos

Sponsored by: